|
|
|
RESEARCH COMMUNICATION
1 INSERM U597, Biologie et Pathologie des cellules mélanocytaires: de la pigmentation cutanée aux mélanomes, Ligue Nationale contre le Cancer, Equipe labellisée 2001, 06107 NICE Cedex 2, France; 2 INSERM U526, Physiopathologie de la mort et la survie cellulaires, Ligue Nationale contre le Cancer, Equipe labellisée 2003, 06107 NICE Cedex 2, France
Microphthalmia-associated transcription factor (MITF) M-form is a melanocyte-specific transcription factor that plays a key role in melanocyte development, survival, and differentiation. Here, we identified MITF as a new substrate of caspases and we characterized the cleavage site after Asp 345 in the C-terminal domain. We show that expression of a noncleavable form of MITF renders melanoma cells resistant to apoptotic stimuli, and we found that the C-terminal fragment generated upon caspase cleavage is endowed with a proapoptotic activity that sensitizes melanoma cells to death signals. The proapoptotic function gained by MITF following its processing by caspases provides a tissue-restricted means to modulate death in melanocyte and melanoma cells.
[Keywords: Apoptosis; caspase; melanoma; MITF]
Received December 24, 2004; revised version accepted June 28, 2005.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.335905.
E-MAIL bertolot{at}unice.fr; FAX 33-4-93-81-14-04.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Chiaverini, L. Beuret, E. Flori, R. Busca, P. Abbe, K. Bille, P. Bahadoran, J.-P. Ortonne, C. Bertolotto, and R. Ballotti Microphthalmia-associated Transcription Factor Regulates RAB27A Gene Expression and Controls Melanosome Transport J. Biol. Chem., May 2, 2008; 283(18): 12635 - 12642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ugurel, R. Houben, D. Schrama, H. Voigt, M. Zapatka, D. Schadendorf, E. B. Brocker, and J. C. Becker Microphthalmia-Associated Transcription Factor Gene Amplification in Metastatic Melanoma Is a Prognostic Marker for Patient Survival, But Not a Predictive Marker for Chemosensitivity and Chemotherapy Response Clin. Cancer Res., November 1, 2007; 13(21): 6344 - 6350. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Passeron, J. C. Valencia, C. Bertolotto, T. Hoashi, E. Le Pape, K. Takahashi, R. Ballotti, and V. J. Hearing SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation PNAS, August 28, 2007; 104(35): 13984 - 13989. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Beuret, E. Flori, C. Denoyelle, K. Bille, R. Busca, M. Picardo, C. Bertolotto, and R. Ballotti Up-regulation of MET Expression by {alpha}-Melanocyte-stimulating Hormone and MITF Allows Hepatocyte Growth Factor to Protect Melanocytes and Melanoma Cells from Apoptosis J. Biol. Chem., May 11, 2007; 282(19): 14140 - 14147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo, K. S. Hoek, A. Testori, L. Larue, and C. R. Goding Mitf regulation of Dia1 controls melanoma proliferation and invasiveness Genes & Dev., December 15, 2006; 20(24): 3426 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Manga, D. Sheyn, F. Yang, R. Sarangarajan, and R. E. Boissy A Role for Tyrosinase-Related Protein 1 in 4-tert-Butylphenol-Induced Toxicity in Melanocytes: Implications for Vitiligo Am. J. Pathol., November 1, 2006; 169(5): 1652 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. de la Serna, Y. Ohkawa, C. Higashi, C. Dutta, J. Osias, N. Kommajosyula, T. Tachibana, and A. N. Imbalzano The Microphthalmia-associated Transcription Factor Requires SWI/SNF Enzymes to Activate Melanocyte-specific Genes J. Biol. Chem., July 21, 2006; 281(29): 20233 - 20241. [Abstract] [Full Text] [PDF] |
||||